Type / Class
Equity / Common shares, US$0.001 nominal value per share
Shares outstanding
1.85B
Number of holders
39
Total 13F shares, excl. options
15.6M
Shares change
+541K
Total reported value, excl. options
$374M
Value change
+$13M
Put/Call ratio
0.8
Number of buys
14
Number of sells
-11
Price
$24.01

Significant Holders of VEON Ltd. - Common shares, US$0.001 nominal value per share (VEON) as of Q1 2024

43 filings reported holding VEON - VEON Ltd. - Common shares, US$0.001 nominal value per share as of Q1 2024.
VEON Ltd. - Common shares, US$0.001 nominal value per share (VEON) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15.6M shares of 1.85B outstanding shares and own 0.84% of the company stock.
Largest 10 shareholders include Lingotto Investment Management LLP (5.33M shares), SHAH CAPITAL MANAGEMENT (4.95M shares), Helikon Investments Ltd (2.53M shares), Solus Alternative Asset Management LP (812K shares), WELLINGTON MANAGEMENT GROUP LLP (572K shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (501K shares), CITIGROUP INC (190K shares), GABELLI FUNDS LLC (129K shares), Russell Investments Group, Ltd. (88K shares), and MORGAN STANLEY (80.8K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.